Erratum: Association of cryptorchidism with a specific haplotype of the estrogen receptor α gene: Implication for the susceptibility to estrogenic environmental endocrine disruptors (The Journal of Clinical Endocrinology and Metabolism (2005) 90:8 (4716-4721) DOI: 10.1210/jc.2005-0211);Association of cryptorchidism with a specific haplotype of the estrogen receptor α gene: Implication for the susceptibility to estrogenic environmental endocrine disruptors

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 8, 2005, Pages 4716-4721

  Yoshida, Rie ^a,c   Fukami, Maki ^a   Sasagawa, Isoji ^b   Hasegawa, Tomonobu ^c   Kamatani, Naoyuki ^d,e   Ogata, Tsutomu ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d Japan Biological Information Research Center   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; DISEASE ASSOCIATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENOMICS; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL;

EID: 23844471536     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/clinem/dgaa685     Document Type: Erratum

References (39)

1. Hutson JM, Hasthorpe S, Heyns CF 1997 Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 18:259-280
2. Ivell R, Hartung S 2003 The molecular basis of cryptorchidism. Mol Hum Reprod 9:175-181
3. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J 2004 Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264-1269
4. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette Jr LJ, Jegou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Muller J, Rajpert-De Meyts E, Scheike T, Sharpe R, Sumpter J, Skakkebaek NE 1996 Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104(Suppl 4):741-803
5. McLachlan JA 2001 Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22:319-341
6. Stillman RJ 1982 In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 142:905-921
7. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
8. O'Donnell L, Robertson KM, Jones ME, Simpson ER 2001 Estrogen and spermatogenesis. Endocr Rev 22:289-318
9. Suzuki Y, Sasagawa I, Itoh K, Ashida J, Ogata T 2002 5α-Reductase type 2 genes in Japanese males do not appear to be associated with cryptorchidism. Fertil Steril 78:330-334
10. Suzuki Y, Sasagawa I, Ashida J, Nakada T, Muroya K, Ogata T 2001 Screening for mutations of the androgen receptor gene in patients with isolated cryptorchidism. Fertil Steril 76:834-836
11. Makridakis NM, di Salle E, Reichardt JK 2000 Biochemical and pharmacogenetic dissection of human steroid 5α-reductase type II. Pharmacogenetics 10:407-413
12. Sasagawa I, Suzuki Y, Tateno T, Nakada T, Muroya K, Ogata T 2000 CAG repeat length of the androgen receptor gene in Japanese males with cryptorchidism. Mol Hum Reprod 6:973-975
13. Lim HN, Chen H, McBride S, Dunning AM, Nixon RM, Hughes IA, Hawkins JR 2000 Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Mol Genet 9:829-834
14. Foresta C, Moro E, Garolla A, Onisto M, Ferlin A 1999 Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocrinol Metab 84:3660-3665
15. De La Vega FM, Dailey D, Ziegle J, Williams J, Madden D, Gilbert DA 2002 New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies. Biotechniques 32:S48-S54
16. Terwilliger JD, Ott J 1994 Handbook of human genetic linkage. Baltimore: Johns Hopkins University Press
17. Lewontin RC 1964 The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 49:49-67
18. Kruglyak L 1999 Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139-144
19. Davidson S 2000 Research suggests importance of haplotypes over SNPs. Nat Biotechnol 18:1134-1135
20. Excoffier L, Slatkin M 1995 Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
21. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N 2002 Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 66:183-193
22. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, Chakravarti A 2003 Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 13:173-181
23. Kamatani N, Sekine A, Kitamoto T, Iida A, Saito S, Kogame A, Inoue E, Kawamoto M, Harigai M, Nakamura Y 2004 Large scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet 75:190-203
24. Ito T, Inoue E, Kamatani N 2004 Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations, and diplotype-based penetrances. Genetics 168:2339-2348
25. Shupnik MA 2002 Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J Neuroendocrinol 14:85-94
26. Nef S, Shipman T, Parada LF 2000 A molecular basis for estrogen-induced cryptorchidism. Dev Biol 224:354-361
27. Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO 2000 Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141:846-849
28. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM 1999 Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13:681-691
29. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295-299
30. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF 2000 Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 85:4013-4018
31. Majdic G, Sharpe RM, O'Shaughnessy PJ, Saunders PT 1996 Expression of cytochrome P450 17α-hydroxylase/C17-20 lyase in the fetal rat testis is reduced by maternal exposure to exogenous estrogens. Endocrinology 137:1063-1070
32. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI 2000 Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
33. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T 2002 Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
34. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K 2003 An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341-348
35. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP 1998 Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res 49(Suppl 1):2-8
36. Martin RM, Lin CJ, Nishi MY, Billerbeck AE, Latronico AC, Russell DW, Mendonca BB 2003 Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. J Clin Endocrinol Metab 88:3027-3034
37. Lorentzon M, Lorentzon R, Backstrom T, Nordstrom P 1999 Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study. J Clin Endocrinol Metab 84:4597-4601
38. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER 2002 Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346:967-974
39. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, Levy D 2003 Association between estrogen receptor gene variation and cardiovascular disease. JAMA 290:2263-2270